MD Medical Group and VTB launch a new insurance product
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has launched an insurance product in cooperation with VTB Insurance, part of VTB Group.
“Protect Your Future” is a healthcare insurance programme, designed for Russian citizens.
Insurance coverage is up to RUB 450,000 with a one-off insurance premium of RUB 15,000. The product will be offered at local branches of the VTB bank, which, given the access it provides to the bank’s clients, will expand the Company’s patient base and increase the number of patient visits.
Medical services available under the insurance programme will be offered at MDMG hospitals and clinics in a number of Russian regions. In addition, patients will gain access via telemedicine to online consultations with the doctor who carried out their medical examination to discuss results and to receive further treatment if required. Technological and service support is provided via the telemedicine platform Doctis.
“We believe that this project is a step towards improving the accessibility of our high-tech services in regions across Russia. With its help more patients will be able to receive comprehensive medical examinations at our facilities.“We are pleased to develop and expand our relationship with our strategic partner VTB, with whom over many years we have implemented a number of important projects for Russia. Our new joint initiative will help many people to receive high-quality medical care on a regular basis.”
For further information please contact:
|
Investors |
Media |
|
Dmitry Yakushkin
MD Medical Group Investments Plc
Tel: +7 495 331 4120 d.yakushkin@mcclinics.ru |
EM
Tom Blackwell: +7 919 102 9064 Sergii Pershyn: +1 929 855 8188
|
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 37 modern healthcare facilities, including 5 hospitals and 32 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, and Nizhny Novgorod.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.